News Announcement

Molbio Diagnostics: Board Meeting Intimation for To Consider And Approve The Financial Results For The Quarter Ended 30 June 2026.

Molbio Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve To consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2026.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan